- Sana Biotechnology Inc (NASDAQ:SANA) has entered into a lease agreement to develop a 163,000 square foot manufacturing facility in Fremont, California.
- The facility will support the manufacture of Sana’s late-stage clinical development and early commercial product candidates.
- The facility will be designed to provide manufacturing capabilities across Sana’s portfolio, including allogeneic T cell, viral vector, and pluripotent stem cell production.
- The Company also plans to work with contract manufacturing partners to advance its product candidates to the clinic as early as next year.
- Price Action: SANA shares closed at $17.42 on Wednesday.
Looking Into American Eagle Outfitters’s Return On Capital Employed
Looking at Q1, American Eagle Outfitters (NYSE:AEO) earned $133.43 million, a 3623.89% increase from the preceding quarter. American Eagle Outfitters's sales decreased to $1.03 billion, a 19.89% change since Q4. In Q4, American Eagle Outfitters brought in $1.29 billion in sales but only earned $3.58 million.
